Table 1.
Number of COVID-19 clinical trials that includes anticoagulant drugs [6].
| Total |
Recruiting | Completed | Not yet |
Active, not |
|
|---|---|---|---|---|---|
| trials | recruiting | recruiting | |||
| Heparin | 112a | 36 | 41 | 14 | 3 |
| Warfarin | 1 | 0 | 1 | 0 | 0 |
| Dabigatran | 3 | 1 | 2 | 0 | 0 |
| Rivaroxaban | b19 | 8 | 6 | 1 | 0 |
| Apixaban | 11 | 6 | 2 | 1 | 1 |
| Edoxaban | 3 | 2 | 1 | 0 | 0 |
2 CTs is enrolling by invitation, 5 CTs having got terminated, and 4 CTs withdrawn.
3 CTs having got terminated.